Addressing the Intersecting Problems of Opioid Misuse and Chronic Pain Treatment

Experimental and Clinical Psychopharmacology

Volumn 16, Issue 5, 2008, Pages 417-428

  Denisco, Richard A ^a   Chandler, Redonna K ^a   Compton, Wilson M ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

chronic pain; drug addiction; National Institute on Drug Abuse NIDA ; prescription opioid misuse; prevalence of opioid abuse

Indexed keywords

DIAMORPHINE; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; ILLICIT DRUG; METHADONE; NARCOTIC ANALGESIC AGENT; OPIATE; OXYCODONE; PAREGORIC; PENTAZOCINE; PERCOCET;

ARTICLE; CHRONIC PAIN; CLINICAL PRACTICE; DRUG MECHANISM; DRUG MISUSE; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; MORTALITY; PRESCRIPTION; PREVALENCE; SOCIAL PROBLEM;

AGE FACTORS; ANALGESICS, OPIOID; CHRONIC DISEASE; HUMANS; OPIOID-RELATED DISORDERS; PAIN; SEX FACTORS; TERMINOLOGY AS TOPIC;

EID: 54049136988     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0013636     Document Type: Article

References (87)

1. Adams N.J., Plane M.B., Fleming M.F., Mundt M.P., Saunders L.A., and Stauffacher E.A. Opioids and the treatment of chronic pain in a primary care sample. Journal of Pain and Symptom Management 22 3 (2001) 791-796
2. American Pain Society. Decade of Pain Report. American Pain Society Bulletin 12 4 (2002). http://www.ampainsoc.org/pub/bulletin/jul02/pres.htm July/August 2002. Retrieved September 1, 2008, from http://www.ampainsoc.org/pub/bulletin/jul02/pres.htm
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-IV (1994), American Psychiatric Association, Washington DC
4. Ashburn M.A., and Staats P.S. The management of chronic pain. Lancet 353 (1999) 1865
5. Automation of Reports and Consolidated Orders System. (n. d.). Retrieved May 3, 2007, from U. S. Department of Justice Web site: http://www.deadiversion.usdoj.gov/arcos/
6. Ballantyne J.C. Chronic pain following treatment for cancer: The role of opioids. Oncologist 8 6 (2003) 567-575
7. Ballantyne J.C. Opioid misuse in oncology pain patients. Current Pain and Headache Reports 11 4 (2007) 276-282
8. Ballantyne J.C., and Mao J. Opioid therapy for chronic pain. New England Journal of Medicine 349 20 (2003) 1943-1953
9. Blengini C., Joranson D., and Ryan K. Italy reforms national policy for cancer pain relief and opioids. European Journal of Cancer Care 12 1 (2003) 28-34
10. Blyth F.M., March L.M., Brnabic A.J., Jorm L.R., Williamson M., and Cousins M.J. Chronic pain in Australia: A prevalence study. Pain 89 2-3 (2001) 127-134
11. Boyd C.J., McCabe S.E., Cranford J.A., and Young A. Adolescents' motivations to abuse prescription medications. Pediatrics 118 6 (2006) 2472-2480
12. Caudill-Slosberg M.A., Schwartz L.M., and Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 109 3 (2004) 514-519
13. Centers for Disease Control and Prevention. New report finds millions in pain (2007). http://www.cdc.gov/nchs/pressroom/06facts/hus06.htm Retrieved December 17, 2007, from http://www.cdc.gov/nchs/pressroom/06facts/hus06.htm
14. Ciccone D.S., Just N., Bandilla E.B., Reimer E., Ilbeigi M.S., and Wu W. Psychological correlates of opioid use in patients with chronic nonmalignant pain: A preliminary test of the downhill spiral hypothesis. Journal of Pain and Symptom Management 20 3 (2000) 180-192
15. Cicero T.J., and Inciardi J.A. Diversion and abuse of methadone prescribed for pain management. Journal of the American Medical Association 293 3 (2005) 297-298
16. Cicero T.J., Inciardi J.A., and Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. Journal of Pain 6 10 (2005) 662-672
17. Cicero T.J., Inciardi J.A., and Surratt H. Trends in the use and abuse of branded and generic extended release oxycodone and fentanyl products in the United States. Drug and Alcohol Dependence 91 2-3 (2007) 115-120
18. Collett B.-J. Opioid tolerance: The clinical perspective. The British Journal of Anaesthesia 81 (1998) 58-68
19. Colliver J.D., Kroutil L.A., Dai L., and Gfroerer J.C. Misuse of prescription drugs: Data from the 2002, 2003, and 2004 National Surveys on Drug Use and Health (2006), Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD
20. Compton W.M., and Volkow N.D. Abuse of prescription drugs and the risk of addiction. Drug and Alcohol Dependence 83 Suppl 1 (2006) S4-7
21. Compton W.M., and Volkow N.D. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence 81 2 (2006) 103-107
22. Eriksen J., Jensen M.K., Sjogren P., Ekholm O., and Rasmusen N.K. Epidemiology of chronic non-malignant pain in Denmark. Pain 106 3 (2000) 221-228
23. Fischer B., Rehm J., Patra J., and Cruz M.F. Changes in illicit opioid use across Canada. Canadian Medical Association Journal 175 11 (2006) 1385
24. Fishbain D.A., Rosomoff H.L., Cutler R.B., and Steele-Rosomoff R. I. Do chronic pain patients' perceptions about their preinjury jobs determine their intent to return to the same type of job post-pain facility treatment?. Clinical Journal of Pain 11 4 (1995) 267-278
25. Fishbain D.A., Rosomoff H.L., Cutler R.B., and Steele-Rosomoff R. Secondary gain concept: A review of the scientific evidence. Clinical Journal of Pain 11 1 (1995) 6-21
26. Gilson A.M., Joranson D.E., Maurer M.A., Ryan K.M., and Garthwaite J.P. Progress to achieve balanced state policy relevant to pain management and palliative care: 2000-2003. Journal of Pain and Palliative Care Pharmacotherapeutics 19 1 (2005) 13-26
27. Gilson A.M., Ryan K.M., Joranson D.E., and Dahl J.L. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. Journal of Pain Symptom Management 28 2 (2004) 176-188
28. Grant B.F., Compton W.M., Crowley T.J., Hasin D.S., Helzer J.E., Li T.K., et al. Errors in assessing DSM-IV substance use disorders. Archives of General Psychiatry 64 3 (2007) 379-380
29. Gureje O., Von Korff M., Simon G.E., and Gater R. Persistent pain and well-being: A World Health Organization study in primary care. Journal of the American Medical Association 280 2 (1998) 147-151
30. Huang B., Dawson D.A., Stinson F.S., Hasin D.S., Ruan W.J., Saha T.D., et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 67 7 (2006) 1062-1073
31. Inciardi J.A., Surratt H.L., Kurtz S.P., and Cicero T.J. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Medicine 8 2 (2007) 171-183
32. International Narcotics Control Board. Press release no. 4: Abuse of prescription drugs to surpass illicit drug abuse. Drug Watch International 12 1 (2007, March). http://www.drugwatch.org/Newsletters/March%202007%20Newsletter.pdf Retrieved December 18, 2007, from http://www.drugwatch.org/Newsletters/March%202007%20Newsletter.pdf
33. Ives T.J., Chelminski P.R., Hammett-Stabler C.A., Malone R.M., Perhac J.S., Potisek N.M., et al. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Services Research 6 (2006) 46
34. Johnston L.D., O'Malley P.M., Bachman J.G., and Schulenberg J.E. Monitoring the future national results on adolescent drug use: Overview of key findings, 2007 (2008), National Institute on Drug Abuse, Bethesda, MD
35. Joranson D.E., Ryan K.M., Gilson A.M., and Dahl J.L. Trends in medical use and abuse of opioid analgesics. Journal of the American Medical Association 283 13 (2000) 1710-1714
36. Katz N. Opioids: After thousands of years, still getting to know you. Clinical Journal of Pain 23 4 (2007) 303-306
37. Katz N.P., Adams E.P., Chilcoat H., Colucci R.D., Comer S.D., Goliber P., et al. Challenges in the development of prescription opioid abuse-deterrent formulations. Clinical Journal of Pain 23 (2007) 648-660
38. Liu Z., Lian Z., and Zhao C. Drug use and HIV/AIDS in China. Drug and Alcohol Review 25 2 (2006) 173-175
39. Luo X., Pietrobon R., and Hey L. Patterns and trends in opioid use among individuals with back pain in the United States. Spine 29 8 (2004) 884-890
40. Mao J. Opioid-induced abnormal pain sensitivity: Implications in clinical opioid therapy. Pain 100 3 (2002) 213-217
41. Mao J. Opioid tolerance and neuroplasticity. Novartis Foundation Symposium 261 (2004) 181-186
42. Mao J. Opioid-induced abnormal pain sensitivity. Current Pain and Headache Reports 10 1 (2006) 67-70
43. Martell B.A., O'Connor P.G., Kerns R.D., Becker W.C., Morales K.H., Kosten T.R., et al. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Annals of Internal Medicine 146 2 (2007) 116-127
44. Martindale. Martindale: The Complete Drug Reference 2007 (2007), Martindale Products-Pharmaceutical Press, London. http://www.thomsonhc.com/hcs/librarian/ND_PR/Drugs/SBK/2/PFPUI/RA16hcq2etOKut/ND_PG/PRIH/CS/529E29/ND_CPR/SearchByDatabase/ND_T/HCS/ND_P/Drugs/DUPLICATIONSHIELDSYNC/ABB2E2/ND_B/HCS/PFActionId/hcs.common.RetrieveDocumentCommon/DocId/6231-p/ContentSetId/30/SearchTerm/dicodid%20/SearchOption/BeginWith Retrieved January 4, 2008, from http://www.thomsonhc.com/hcs/librarian/ND_PR/Drugs/SBK/2/PFPUI/RA16hcq2etOKut/ND_PG/PRIH/CS/529E29/ND_CPR/SearchByDatabase/ND_T/HCS/ND_P/Drugs/DUPLICATIONSHIELDSYNC/ABB2E2/ND_B/HCS/PFActionId/hcs.common.RetrieveDocumentCommon/DocId/6231-p/ContentSetId/30/SearchTerm/dicodid%20/SearchOption/BeginWith
45. Merry A.F., Schug S.A., Richards E.G., and Large R.G. Opioids in the treatment of chronic pain of nonmalignant origin. New Zealand Medical Journal 104 925 (1991) 520-521
46. Merskey H.M., and Bogduk N. Classification of chronic pain, 2nd Edition (1994), International Association for the Study of Pain Press, Seattle
47. Miller N.S., Swiney T., and Barkin R.L. Effects of opioid prescription medication dependence and detoxification on pain perceptions and self-reports. American Journal of Therapeutics 13 5 (2006) 436-444
48. Moore T.J., Cohen M.R., and Furberg C.D. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Archives of Internal Medicine 167 16 (2007) 1752-1759
49. Musto D. The mystery of addiction. Lancet 354 Suppl. (1999) SIV1
50. National Institute on Drug Abuse. Clinical trials network - Research (2008). http://www.nida.nih.gov/CTN/Research.html Retrieved January 31, 2008, from http://www.nida.nih.gov/CTN/Research.html
51. National Institute on Drug Abuse. NIDA research report series - Prescription drugs: Abuse and addiction (2008). http://www.nida.nih.gov/ResearchReports/Prescription/Prescription6a.html Retrieved January 11, 2008, from http://www.nida.nih.gov/ResearchReports/Prescription/Prescription6a.html
52. National Institute on Drug Abuse. NIDA special report - Pain, opioids, and addiction: An urgent problem for doctors and patients, March 5-6 (2008). http://www.drugabuse.gov/whatsnew/meetings/default.html Retrieved January 11, 2008, from http://www.drugabuse.gov/whatsnew/meetings/default.html
53. National Institute on Drug Abuse. Program announcements (2008). http://grants.nih.gov/grants/guide/pa-files/PA-04-110.html Retrieved January 11, 2008, from http://grants.nih.gov/grants/guide/pa-files/PA-04-110.html
54. National Institute on Drug Abuse. Request for applications (2008). http://www.nida.nih.gov/Funding/rfa06.html Retrieved January 11, 2008, from http://www.nida.nih.gov/Funding/rfa06.html
55. National Institute on Drug Abuse. Small Business Innovation Research (SBIR) and Technology Transfer (STTR) programs (2008). http://www.nida.nih.gov/Funding/SBIR_STTR.html Retrieved January 31, 2008, from http://www.nida.nih.gov/Funding/SBIR_STTR.html
56. Paulozzi L.J., Budnitz D.S., and Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiology and Drug Safety 15 9 (2006) 618-627
57. Perkonigg A., Pfister H., Hofler M., Frohlich C., Zimmermann P., Lieb R., et al. Substance use and substance use disorders in a community sample of adolescents and young adults: Incidence, age effects and patterns of use. European Addiction Research 12 4 (2006) 187-196
58. Portenoy R.K. Appropriate use of opioids for persistent non-cancer pain. Lancet 364 9436 (2004) 739-740
59. Portenoy R.K., and Foley K.M. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain 25 2 (1986) 171-186
60. Reid M.C., Engles-Horton L.L., Weber M.B., Kerns R.D., Rogers E.L., and O'Connor P.G. Use of opioid medications for chronic noncancer pain syndromes in primary care. Journal of General Internal Medicine 17 3 (2002) 173-179
61. Rosomoff H.L., Fishbain D.A., Cutler R.B., and Steele-Rosomoff R. II. Do chronic pain patients' perceptions about their preinjury jobs differ as a function of worker compensation and non-worker compensation status?. Clinical Journal of Pain 11 4 (1995) 279-286
62. Schofferman J. Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin. Journal of Pain and Symptom Management 8 5 (1993) 279-288
63. Schug S.A., Merry A.F., and Acland R.H. Treatment principles for the use of opioids in pain of nonmalignant origin. Drugs 42 2 (1991) 228-239
64. Simoni-Wastila L. The use of abusable prescription drugs: The role of gender. Journal of Women's Health and Gender-based Medicine 9 3 (2000) 289-297
65. Simoni-Wastila L., Ritter G., and Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Substance Use and Misuse 39 1 (2004) 1-23
66. Stewart W.F., Ricci J.A., Chee E., and Morganstein D. Lost productive time and cost due to common pain conditions in the U.S. workforce. Journal of the American Medical Association 290 (2003) 2443-2454
67. Strine T.W., Hootman J.M., Chapman D.P., Okoro C.A., and Balluz L. Health-related quality of life, health-risk behaviors, and disability among adults with pain related activity disability. American Journal of Public Health 95 11 (2005) 2042-2048
68. Substance Abuse and Mental Health Services Administration. Mortality data from DAWN, 2002 DAWN Series D-25 (DHHS Publication No. SM) 04-3875) (2004), Author, Rockville, MD
69. Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2002: The DAWN Report, Oxycodone, Hydrocodone, and Polydrug Use, 2002 (2004). http://www.oas.samhsa.gov/2k4/oxycodone/oxycodone.pdf Office of Applied Studies. The DAWN Report, July, 2004. Retrieved January 8, 2008 and September 1, 2008 from http://www.oas.samhsa.gov/2k4/oxycodone/oxycodone.pdf
70. Substance Abuse and Mental Health Services Administration. Emergency Department Visits Involving Nonmedical Use of Selected Pharmaceuticals 2004 (2006), Author, Rockville, MD
71. Substance Abuse and Mental Health Services Administration. The NSDUH Report: Patterns and Trends in Nonmedical Prescription Pain Reliever Use: 2002 to 2005 (2007), Author, Rockville, MD
72. Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2005: National estimates of drug-related emergency department visits DAWN Series D-29 (DHHS Publication No. SMA 07-4256) (2007), Author, Rockville, MD
73. Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on drug use and health: National findings, NSDUH Series H-32 (DHHS Publication No. SMA 07-4293) (2007), Author, Rockville, MD
74. Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS): 1995-2005. National admissions to substance abuse treatment services, DASIS Series: S-37 (DHHS Publication No. SMA 07-4234) (2007), Author, Rockville, MD
75. United States Food and Drug Administration, Center for Drug Evaluation and Research. Adverse Event Reporting System (AERS) (2007, March). http://www.fda.gov/cder/aers/default.htm Retrieved December 18, 2007, from http://www.fda.gov/cder/aers/default.htm
76. Vivian J., Saleheen H., Singer M., Navarro J., and Mirhej G. Under the counter: The diffusion of narcotic analgesics to the inner city street. Journal of Ethnic Substance Abuse 4 2 (2005) 97-114
77. Von Korff M. Editorial: Potent opioids for chronic musculoskeletal pain: Flying blind?. Pain 109 (2004) 207-209
78. Webster L.R., and Webster R.M. Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the opioid risk tool. Pain Medicine 6 6 (2005) 432-442
79. Wijnhoven A., de Vet H., and Picavet S. Prevalence of musculoskeletal disorders is systematically higher in women than in men. Clinical Journal of Pain 22 (2006) 717-724
80. Winkler J., Mueller U., Nenoff P., Seyfarth H.-J., Vogtmann M., Borte G., et al. Treatment of invasive pulmonary aspergillosis in neutropenic patients by additional bronchoscopic Amphotericin B instillation. Respiration 74 6 (2007) 663-673
81. World Health Organization. Cancer pain relief (1986), Author, Geneva, Switzerland
82. World Health Organization. Achieving balance in national opioids control policy. Guidelines for assessment (2000), Author, Geneva, Switzerland
83. Wysowski D.K. Surveillance of prescription drug-related mortality using death certificate data. Drug Safety 30 6 (2007) 533-540
84. Zacny J., Bigelow G., Compton P., Foley K., Iguchi M., and Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug and Alcohol Dependence 69 3 (2003) 215-232
85. Zenz M., Strumpf M., and Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. Journal of Pain and Symptom Management 7 2 (1992) 69-77
86. Zenz M., and Willweber-Strumpf A. Opiophobia and cancer pain in Europe. Lancet 341 (1993) 1075-1076
87. Zhu K., Devine A., Dick I., and Prince R.L. Association of back pain frequency with mortality, coronary heart events, mobility, and quality of life in elderly women. Spine 32 18 (2007) 2012-2018